Cross talk between epidermal growth factor (EGF) receptor and extra nuclear steroid receptors in cell lines

[1]  E. Levin.  Plasma membrane estrogen receptors , 2009, Trends in Endocrinology & Metabolism.

[2]  S. Fuqua,et al.  G protein-coupled receptor 30 expression is up-regulated by EGF and TGF alpha in estrogen receptor alpha-positive cancer cells. , 2009, Molecular endocrinology.

[3]  J. Andrade,et al.  Novel actions of estrogen to promote proliferation: Integration of cytoplasmic and nuclear pathways , 2009, Steroids.

[4]  Simak Ali,et al.  Regulation of ERBB2 by oestrogen receptor–PAX2 determines response to tamoxifen , 2008, Nature.

[5]  I. Treilleux,et al.  Regulation of estrogen rapid signaling through arginine methylation by PRMT1. , 2008, Molecular cell.

[6]  Andrea Riccardo Genazzani,et al.  Extra-Nuclear Signalling of Estrogen Receptor to Breast Cancer Cytoskeletal Remodelling, Migration and Invasion , 2008, PloS one.

[7]  Jason M. Held,et al.  A novel serine phosphorylation site detected in the n-terminal domain of estrogen receptor isolated from human breast cancer cells , 2008, Journal of the American Society for Mass Spectrometry.

[8]  E. Appella,et al.  Inhibition of Estradiol Receptor/Src Association and Cell Growth by an Estradiol Receptor α Tyrosine-Phosphorylated Peptide , 2007, Molecular Cancer Research.

[9]  E. Appella,et al.  Inhibition of the SH3 domain-mediated binding of Src to the androgen receptor and its effect on tumor growth , 2007, Oncogene.

[10]  Tony Pawson,et al.  Dynamic control of signaling by modular adaptor proteins. , 2007, Current opinion in cell biology.

[11]  D. Márquez,et al.  Epidermal growth factor receptor and tyrosine phosphorylation of estrogen receptor , 2001, Endocrine.

[12]  C. J. Barnes,et al.  P21-activated kinase 1 regulation of estrogen receptor-alpha activation involves serine 305 activation linked with serine 118 phosphorylation. , 2006, Cancer research.

[13]  A. Bilancio,et al.  Steroid receptor regulation of epidermal growth factor signaling through Src in breast and prostate cancer cells: steroid antagonist action. , 2005, Cancer research.

[14]  E. Levin,et al.  Integration of the extranuclear and nuclear actions of estrogen. , 2005, Molecular endocrinology.

[15]  B. O’Malley.  A life-long search for the molecular pathways of steroid hormone action. , 2005, Molecular endocrinology.

[16]  K. Korach,et al.  Lessons in estrogen biology from knockout and transgenic animals. , 2005, Annual review of physiology.

[17]  J. Gustafsson,et al.  Estrogen Receptor in Prostate Cancer , 2004 .

[18]  A. Bilancio,et al.  Role of Atypical Protein Kinase C in Estradiol-Triggered G1/S Progression of MCF-7 Cells , 2004, Molecular and Cellular Biology.

[19]  R. Schiff,et al.  Mechanisms of tamoxifen resistance: increased estrogen receptor-HER2/neu cross-talk in ER/HER2-positive breast cancer. , 2004, Journal of the National Cancer Institute.

[20]  L. Silengo,et al.  p130Cas interacts with estrogen receptor α and modulates non-genomic estrogen signaling in breast cancer cells , 2004, Journal of Cell Science.

[21]  Christopher J. Barnes,et al.  The role of Shc and insulin-like growth factor 1 receptor in mediating the translocation of estrogen receptor α to the plasma membrane , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[22]  J. Gustafsson,et al.  Estrogen receptor beta in prostate cancer. , 2004, The New England journal of medicine.

[23]  A. Bilancio,et al.  Androgen-stimulated DNA synthesis and cytoskeletal changes in fibroblasts by a nontranscriptional receptor action , 2003, The Journal of cell biology.

[24]  E. Levin,et al.  Proximal Events in Signaling by Plasma Membrane Estrogen Receptors* , 2003, The Journal of Biological Chemistry.

[25]  R. Schiff,et al.  Breast cancer endocrine resistance: how growth factor signaling and estrogen receptor coregulators modulate response. , 2003, Clinical cancer research : an official journal of the American Association for Cancer Research.

[26]  A. Cato,et al.  Rapid Actions of Steroid Receptors in Cellular Signaling Pathways , 2002, Science's STKE.

[27]  Chi-Hung Lin,et al.  Resistance to tamoxifen‐induced apoptosis is associated with direct interaction between Her2/neu and cell membrane estrogen receptor in breast cancer , 2002, International journal of cancer.

[28]  A. Bilancio,et al.  PI3‐kinase in concert with Src promotes the S‐phase entry of oestradiol‐stimulated MCF‐7 cells , 2001, The EMBO journal.

[29]  Simak Ali,et al.  Phosphatidylinositol 3-Kinase/AKT-mediated Activation of Estrogen Receptor α , 2001, The Journal of Biological Chemistry.

[30]  B. Katzenellenbogen,et al.  Nongenotropic, Sex-Nonspecific Signaling through the Estrogen or Androgen Receptors Dissociation from Transcriptional Activity , 2001, Cell.

[31]  A. Bilancio,et al.  Steroid‐induced androgen receptor–oestradiol receptor β–Src complex triggers prostate cancer cell proliferation , 2000, The EMBO journal.

[32]  K. Bland,et al.  Estrogen-induced activation of Erk-1 and Erk-2 requires the G protein-coupled receptor homolog, GPR30, and occurs via trans-activation of the epidermal growth factor receptor through release of HB-EGF. , 2000, Molecular endocrinology.

[33]  K. Ley,et al.  Interaction of oestrogen receptor with the regulatory subunit of phosphatidylinositol-3-OH kinase , 2000, Nature.

[34]  J. Font de Mora,et al.  AIB1 Is a Conduit for Kinase-Mediated Growth Factor Signaling to the Estrogen Receptor , 2000, Molecular and Cellular Biology.

[35]  Wen-rong Gong,et al.  Activation of the Src/p21ras/Erk pathway by progesterone receptor via cross‐talk with estrogen receptor , 1998, The EMBO journal.

[36]  A. Bilancio,et al.  Estradiol activation of human colon carcinoma-derived Caco-2 cell growth. , 1996, Cancer research.

[37]  Daniel Metzger,et al.  Activation of the Estrogen Receptor Through Phosphorylation by Mitogen-Activated Protein Kinase , 1995, Science.

[38]  M. Sliwkowski,et al.  HER-2 tyrosine kinase pathway targets estrogen receptor and promotes hormone-independent growth in human breast cancer cells. , 1995, Oncogene.

[39]  S. F. Arnold,et al.  Phosphorylation of the human estrogen receptor on tyrosine 537 in vivo and by src family tyrosine kinases in vitro. , 1995, Molecular endocrinology.

[40]  K. Korach,et al.  Coupling of dual signaling pathways: epidermal growth factor action involves the estrogen receptor. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[41]  W Godolphin,et al.  Studies of the HER-2/neu proto-oncogene in human breast and ovarian cancer. , 1989, Science.

[42]  H. Rochefort,et al.  Antiestrogens inhibit the mitogenic effect of growth factors on breast cancer cells in the total absence of estrogens. , 1987, Biochemical and biophysical research communications.